Stay updated on Pembrolizumab in mCRPC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in mCRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in mCRPC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The study record area now shows a 403 Forbidden message with a Home link. A sitewide NIH announcement about terminology during the transition from “Artificial Intelligence” to “Super Intelligence” is also displayed.
    Difference
    2%
    Check dated 2026-10-25T13:08:50.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-18T14:08:04.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T14:47:41.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the study record, indicating the page is inaccessible, with the surrounding header and footer visible while the main content area displays an error message.
    Difference
    20%
    Check dated 2026-09-20T19:47:43.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6 instead of the previous v3.6.5, indicating a routine site update.
    Difference
    0.1%
    Check dated 2026-08-30T08:19:41.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    The page now displays revision v3.6.5, replacing the previous revision v3.6.4. This indicates a minor site update or patch to the ClinicalTrials.gov interface.
    Difference
    0.1%
    Check dated 2026-08-08T22:33:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in mCRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in mCRPC Clinical Trial page.